35 results
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
or in vitro data to support the initiation of human clinical studies;
the occurrence of a pandemic or the spread of a virus that diverts the attention … of regulatory agencies from reviewing our study design or results or which, as a result of such pandemic or widespread, requires us to materially modify
6-K
EX-99.2
SPRC
SciSparc Ltd
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
or that the term of such capital raise will be on terms favorable to us. In addition, as we continue to assess the effects of the COVID-19 pandemic and its … 2022 offerings, all of which were during the COVID-19 pandemic, there can be no assurance that we will be able to raise financing again during
6-K
EX-99.1
SPRC
SciSparc Ltd
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
:- SIGNIFICANT EVENTS DURING THE REPORTING PERIOD
There has been no material impact of the COVID-19 pandemic on the Company’s operations during the reporting … implications of the COVID-19 pandemic are difficult to estimate at this stage, it is clear that it has affected the lives of a large portion
6-K/A
EX-99.1
1298 az90x
26 Aug 21
Current report (foreign) (amended)
4:42pm
6-K
EX-99.2
3r6vgsj1h7g z08e
16 Aug 21
Interim Consolidated Financial Statements
12:00am
6-K
EX-99.1
l261prfdx3he8f8
16 Aug 21
Interim Consolidated Financial Statements
12:00am
6-K
EX-99.1
6t3 1g0ly
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
EX-99.2
2k7t tgj9sb7y
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
EX-99.2
lqe3we54o4s 3wh
2 Dec 20
Special General Meeting of Shareholders
4:02pm
6-K
EX-99.1
bc69soztnu6c p8x6
2 Dec 20
Special General Meeting of Shareholders
4:02pm
424B4
pafsk59
20 Nov 20
Prospectus supplement with pricing info
4:43pm
F-1/A
s4nx4
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
0fuu9 3xl9
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
6-K
mso14ygmt6
14 Oct 20
Current report (foreign)
4:02pm
6-K
EX-99.2
ljcgww6ra
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1/A
t3p1j6qe
9 Oct 20
Registration statement (foreign) (amended)
12:00am